Dubow Adam — SEC Form 4 filings
SEC reporting owner CIK 1744507. 14 Form 4 filings on record with FilingPulse; latest filed 2026-04-23.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-01-09 to 2026-04-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 9 filings — 37,139 shares, $414,669 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 90.
- Largest priced transaction: sale of 6,395 shares @ $11.60 ($74,188) in Day One Biopharmaceuticals, Inc., filed 2026-02-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. (DAWN) | Gen Counsel & Secretary | 14 | — | 9 legs · 37,139 sh · $414,669 | 90 |
Form 4 filings — Dubow Adam
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-23 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to issuer (D): 72,694 · Disposition to issuer (D): 309,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · +5 more | EDGAR |
| 2026-02-18 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 2,963 · Option exercise (M): 1,750 · Option exercise (M): 3,688 · Option exercise (M): 3,687 · Option exercise (M): 4,375 · Sale (S): 6,395 @ $11.60 · +5 more | EDGAR |
| 2026-01-30 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 105,000 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 2,963 · Option exercise (M): 1,750 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 4,319 @ $8.91 · Option exercise (M): 2,963 (derivative) @ $0 · +3 more | EDGAR |
| 2025-11-07 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 309,000 (derivative) @ $0 · Disposition to issuer (D): 90,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 · Disposition to issuer (D): 90,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 · Disposition to issuer (D): 90,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-08-19 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 2,963 · Option exercise (M): 1,750 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 4,365 @ $6.77 · Option exercise (M): 2,963 (derivative) @ $0 · +3 more | EDGAR |
| 2025-05-19 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 2,962 · Option exercise (M): 1,750 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 4,552 @ $6.26 · Option exercise (M): 2,962 (derivative) @ $0 · +3 more | EDGAR |
| 2025-02-21 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 2,962 · Option exercise (M): 1,750 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 4,646 @ $11.96 · Option exercise (M): 2,962 (derivative) @ $0 · +3 more | EDGAR |
| 2025-01-31 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 59,000 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 2,962 · Option exercise (M): 1,750 · Option exercise (M): 3,687 · Sale (S): 3,165 @ $13.21 · Option exercise (M): 2,962 (derivative) @ $0 · Option exercise (M): 1,750 (derivative) @ $0 · +1 more | EDGAR |
| 2024-08-19 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 2,962 · Option exercise (M): 1,750 · Option exercise (M): 3,687 · Sale (S): 3,202 @ $14.00 · Option exercise (M): 2,962 (derivative) @ $0 · Option exercise (M): 1,750 (derivative) @ $0 · +1 more | EDGAR |
| 2024-05-17 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 2,962 · Option exercise (M): 1,750 · Option exercise (M): 3,687 · Sale (S): 3,253 @ $16.08 · Option exercise (M): 2,962 (derivative) @ $0 · Option exercise (M): 1,750 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-20 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 2,962 · Option exercise (M): 1,750 · Option exercise (M): 3,687 · Sale (S): 3,242 @ $15.25 · Option exercise (M): 2,962 (derivative) @ $0 · Option exercise (M): 1,750 (derivative) @ $0 · +1 more | EDGAR |
| 2024-01-09 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 59,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1744507 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →